Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
To Dose or Not to Dose?
Prescribing low-dose aspirin for preventing secondary cardiovascular disease is well established, but its safety and efficacy in primary prevention remains open to debate.
Pain, Agitation, and Delirium: A Review of Pertinent Guideline Updates for Pharmacists
Treating pain can help decrease agitation, while limiting sedation can help prevent delirium within the ICU.
Perils of Mixing Opioids, Benzodiazepines
Opioid-related research developments of interest to pharmacists. Worsening Overdose Crisis Predicted
Opioid-related research developments of interest to pharmacists.
Copyright © 2000 - 2025 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.